ALLMedicine™ Cardiogenic Shock Center

May 19th, 2022 - Despite advances in early revascularization, percutaneous hemodynamic support platforms, and systems of care, cardiogenic shock (CS) remains associated with a mortality rate higher than 50%. Several risk stratification models have been derived sin...

May 18th, 2022 - Early assessment of response to Impella in cardiogenic shock may guide escalation of mechanical circulatory support. Therapeutic goal and response to Impella have not previously been defined. This study tested the hypothesis that targeting 3-h pos...

May 18th, 2022 - Cardiogenic shock (CS) often occurs in patients suffering from rapidly progressing end-stage heart failure or acute myocardial infarction. Mechanical circulatory support may be used for patients who do not respond to medication or revascularizatio...

May 18th, 2022 - Mechanical circulatory support (MCS) devices can be used in high-risk percutaneous coronary intervention (PCI). Our objective was to describe trends and outcomes of prophylactic MCS use in elective PCI for patients with stable coronary artery dise...

May 18th, 2022 - Moderate Hypothermia vs Normothermia and 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial ECMO-Reply.|2022|Levy B,Combes A,Girerd N,|

May 5th, 2022 - Scientific background - Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is used more and more frequently in patients with acute myocardial infarction (AMI) and refractory cardiogenic shock despite the absence of high level scientific ev...

May 5th, 2022 - Background: Extracorporeal Membrane Oxygenation (ECMO) is the most frequently used mechanical circulatory support (MCS) for severe forms of cardiogenic shock (CS) when simpler measures like inotropes and the intra-aortic balloon pump fail. Despite...

Apr 12th, 2022 - All patients who meet inclusion criteria and have no exclusion criteria are considered to be enrolled. During the period of study, the participants can decide whether to accept ECMO based on their personal conditions. If a patient is willing to ac...

Apr 11th, 2022 - Current management strategies for patients with SCAI stage C through E cardiogenic shock include management in a cardiac intensive care unit (CICU) or cardiac surgery intensive care unit (CSICU) with intravenous inotropes (i.e. medications to incr...

Apr 4th, 2022 - Short Term Mechanical Circulatory Support (STMCS) are the last resort therapeutics when refractory cardiogenic shock occurs. Growing technical possibilities like impella make the right choice at the right time challenging. At Bordeaux University H...

Apr 21st, 2022 - This article was originally published in French on Medscape. WASHINGTON, DC — By giving Alain Cribier, MD, PhD, professor emeritus at Rouen University Hospital in Rouen, France, the Presidential Citation Award, the American College of Cardiology C...

Apr 7th, 2022 - Findings from the American College of Cardiology (ACC) Global Heart Attack Treatment Initiative (GHATI), aimed at improving guideline-based care and survival of such patients in mainly low- to middle-income countries, are "encouraging," researcher...

Feb 8th, 2022 - The Society for Cardiovascular Angiography and Interventions (SCAI) has refined its cardiogenic shock (CS) classification system based on the literature and clinician feedback from real-world experience. "In the 2 years since publication in 2019, ...

Dec 15th, 2021 - Pheochromocytoma is a rare catecholamine-secreting tumor of chromaffin cells of the adrenal medulla or sympathetic ganglia, occurring in about 0. 2 to 0.

Dec 3rd, 2021 - Key Takeaway A preliminary, unpublished study that used noninvasive diffuse correlation spectroscopy (DCS) to assess cerebral blood flow (CBF) in patients undergoing extracorporeal membrane oxygenation (ECMO) showed that comatose patients have inc...